Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion

Texto completo
Autor(es):
Mostrar menos -
Andrade-Oliveira, Vinicius [1] ; Amano, Mariane T. [1] ; Correa-Costa, Matheus [1] ; Castoldi, Angela [1] ; Felizardo, Raphael J. F. [2] ; de Almeida, Danilo C. [2] ; Bassi, Enio J. [1] ; Moraes-Vieira, Pedro M. [1] ; Hiyane, Meire I. [1] ; Rodas, Andrea C. D. [1] ; Peron, Jean P. S. [3] ; Aguiar, Cristhiane F. [1] ; Reis, Marlene A. [4] ; Ribeiro, Willian R. [5] ; Valduga, Claudete J. [5] ; Curi, Rui [6] ; Ramirez Vinolo, Marco Aurelio [7] ; Ferreira, Caroline M. [6] ; Saraiva Camara, Niels Olsen [2, 1]
Número total de Autores: 19
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Lab Transplantat Immunobiol, Dept Immunol, Inst Biomed Sci 4, BR-05508000 Sao Paulo - Brazil
[2] Univ Fed Sao Paulo, Div Nephrol, Sao Paulo - Brazil
[3] Univ Sao Paulo, Neuroimmune Interact Lab, Dept Immunol, Inst Biomed Sci 4, BR-05508000 Sao Paulo - Brazil
[4] Univ Fed Triangulo Mineiro, Dept Pathol, Uberaba - Brazil
[5] Univ Anhanguera Sao Paulo UNIAN SP, Dept Pharm & Biotechnol, Sao Paulo - Brazil
[6] Univ Sao Paulo, Dept Physiol & Biophys, Inst Biomed Sci 4, BR-05508000 Sao Paulo - Brazil
[7] Univ Campinas UNICAMP, Inst Biol, Dept Genet Evolut & Bioagents, Sao Paulo - Brazil
Número total de Afiliações: 7
Tipo de documento: Artigo Científico
Fonte: JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY; v. 26, n. 8, p. 1877-1888, AUG 2015.
Citações Web of Science: 94
Resumo

Short-chain fatty acids (SCFAs) are fermentation end products produced by the intestinal nnicrobiota and have anti-inflammatory and histone deacetylase inhibiting properties. Recently, a dual relationship between the intestine and kidneys has been unraveled. Therefore, we evaluated the role of SCFA in an AKI model in which the inflammatory process has a detrimental role. We observed that therapy with the three main SCFAs (acetate, propionate, and butyrate) improved renal dysfunction caused by injury. This protection was associated with low levels of local and systemic inflammation, oxidative cellular stress, cell infiltration/activation, and apoptosis. However, it was also associated with an increase in autophagy. Moreover, SCFAs inhibited histone deacetylase activity and modulated the expression levels of enzymes involved in chromatin modification. In vitro analyses showed that SCFAs modulated the inflammatory process, decreasing the maturation of dendritic cells and inhibiting the capacity of these cells to induce CD4(+) and CD8(+) T cell proliferation. Furthermore, SCFAs ameliorated the effects of hypoxia in kidney epithelial cells by improving mitochondria! biogenesis. Notably, mice treated with acetate-producing bacteria also had better outcomes after AKI. Thus, we demonstrate that SCFAs improve organ function and viability after an injury through modulation of the inflammatory process, most likely via epigenetic modification. (AU)

Processo FAPESP: 11/01016-2 - Ácidos graxos de cadeia curta (SCFA) como moduladores da resposta inflamatória na lesão renal aguda e crônica experimental
Beneficiário:Vinicius de Andrade Oliveira
Linha de fomento: Bolsas no Brasil - Doutorado
Processo FAPESP: 12/02270-2 - Novos mecanismos celulares, moleculares e imunológicos das lesões renais agudas e crônicas: busca por novas estratégias terapêuticas
Beneficiário:Niels Olsen Saraiva Câmara
Linha de fomento: Auxílio à Pesquisa - Temático